This announcement is a separate document:
丽珠集团：广东德赛律师事务所关于丽珠医药集团股份有限公司2023年度股东大会、2024年第一次A股类别股东会及2024年第一次H股类别股东会的法律意见书
Livzon Pharmaceutical Group Inc.: Legal opinion by Dacheng Law Firm, regarding Livzon Pharma Group Co., Ltd.'s 2023 shareholder meeting, 2024 first A-share category shareholder meeting, and 2024 first H-share category shareholder meeting.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated